Cambridge Investment Research Advisors, Inc. Second Sight Medical Products Inc Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.4 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022
SELL
$1.63 - $3.41 $26,321 - $55,064
-16,148 Closed
0 $0
Q2 2021

Aug 10, 2021
BUY
$4.94 - $9.43 $79,771 - $152,275
16,148 New
16,148 $79,000

About SECOND SIGHT MEDICAL PRODUCTS INC

EYES Quotes by TradingView
  • Ticker EYES
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 13,136,400
  • Market Cap $54.4M
  • Description
  • Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulati...
More about EYES
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email